Nolpaza (Pantoprazole)

Pantoprazole, the active ingredient in Nolpaza, is a proton pump inhibitor presented as a tablet for oral use. It reduces gastric acid production and is prescribed for conditions such as gastro‑oesophageal reflux disease and related ulcer disorders in adults. It is indicated for the treatment and prevention of acid‑related gastrointestinal disorders in patients requiring long‑term acid suppression.

GNH USA supplies Nolpaza as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product meets EU quality standards and is manufactured under strict GMP conditions.

Pantoprazole is used to manage disorders related to excess gastric acid secretion.

- Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and regurgitation by reducing acid exposure in the esophagus. - Erosive esophagitis: promotes healing of inflamed esophageal tissue caused by acid damage. - Zollinger‑Ellison syndrome: controls severe hyper‑secretion of gastric acid associated with gastrin‑producing tumors. - Prevention of NSAID‑induced gastric ulcers: reduces the risk of ulcer formation in patients receiving non‑steroidal anti‑inflammatory drugs.

Common Side Effects: - Headache: mild to moderate pain often reported during early treatment. - Diarrhea: loose stools that may resolve with continued therapy. - Nausea: transient feeling of sickness, usually mild. - Abdominal pain: discomfort in the stomach area. - Flatulence: increased gas production. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis presenting with watery diarrhea. - Severe allergic reactions: rash, swelling, or anaphylaxis requiring immediate medical attention. - Low magnesium levels (hypomagnesemia): can cause muscle cramps, seizures, or cardiac arrhythmias. - Bone fractures: increased risk with long‑term use, especially in the elderly. - Liver enzyme elevation: signs of hepatic dysfunction such as jaundice.

Before initiating therapy, consider the following precautions: - Assess renal and hepatic function: dose adjustment may be required in impairment. - Use cautiously in the elderly: increased susceptibility to electrolyte disturbances. - Monitor magnesium levels during prolonged treatment. - Avoid abrupt discontinuation: taper to reduce rebound acid hypersecretion. - Review concomitant medications for potential interactions. - Store at ambient temperature: keep in the original pack, protect from moisture.

Pantoprazole may interact with several medicines; awareness of the interaction level helps guide monitoring.

Major Interactions (Avoid): - Ketoconazole and other antifungals requiring acidic pH: reduced absorption and efficacy. - Atazanavir (HIV protease inhibitor): decreased plasma concentrations. - Nelfinavir (HIV protease inhibitor): diminished therapeutic effect.

Moderate Interactions (Monitor Closely): - Clopidogrel: possible reduction in antiplatelet activity. - Methotrexate: increased serum levels, especially at high doses. - Warfarin: potential alteration of anticoagulant effect requiring INR monitoring.